BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1684473)

  • 1. Functionally different Langerhans' cells in human epidermis.
    Warfvinge K; Mikulowska A; Falck B
    Acta Derm Venereol; 1991; 71(5):429-30. PubMed ID: 1684473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
    Crivellato E; Damiani D; Mallardi F
    Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new amino acid transport system in human epidermal Langerhans cells: the L-dopa influx/efflux cycle.
    Bendsöe N
    Ups J Med Sci; 2003; 108(3):161-92. PubMed ID: 15000456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for the visualization of the epidermal Langerhans cell and its application on normal and allergic skin.
    Sjöborg S; Axelsson S; Falck B; Jacobsson S; Ringberg A
    Acta Derm Venereol Suppl (Stockh); 1978; 58(79):23-30. PubMed ID: 278442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro uptake of L-dopa and catecholamines into the epidermal Langerhans cell.
    Axelsson S; Elofsson R; Falck B; Sjöborg S
    Acta Derm Venereol Suppl (Stockh); 1978; 58(79):31-5. PubMed ID: 278443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediated exodus of L-dopa from human epidermal Langerhans cells.
    Falck B; Bendsoe N; Ronquist G
    Amino Acids; 2004 Mar; 26(2):133-8. PubMed ID: 15042441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of the Langerhans cells in the human vaginal epithelium by the L-dopa histofluorescence method.
    Crivellato E; Grill V; Scamperle M; Basa M; Mallardi F
    Z Mikrosk Anat Forsch; 1989; 103(1):102-7. PubMed ID: 2756739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the L-dopa transport system in human epidermal Langerhans cells by omeprazole and its analogues.
    Bendsoe N; Ronquist G
    Amino Acids; 2004 Feb; 26(1):19-26. PubMed ID: 14752612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Amino-n-butyric acid methyl ester induces concentrative uptake of L-dopa in human Langerhans' cells normally not operative for L-dopa transport.
    Falck B; Andersson L; Mikulowska A; Ronquist G
    Acta Derm Venereol; 1993 Jun; 73(3):197-9. PubMed ID: 8105618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Langerhans' cells in normal and eczematous dermatitis skin by CD1a protein immunohistochemistry: preliminary findings.
    Hussein MR
    J Cutan Pathol; 2008 Jun; 35(6):554-8. PubMed ID: 18312440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsets of keratinocytes and Langerhans' cells express epitopes associated with suppressor-inducer capabilities in resting normal human epidermis.
    De Panfilis G; Manara GC; Ferrari C; Torresani C; Rowden G
    Immunology; 1990 Apr; 69(4):622-5. PubMed ID: 1692305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical demonstration of Langerhans' cells in smears and pellets of exfoliated cells from human exocervices.
    Figueroa CD; Concha M; Caorsi I
    Acta Cytol; 1989; 33(2):219-22. PubMed ID: 2929224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for transforming growth factor-beta1 in maintaining the differentiated state of Langerhans cells in human epidermis.
    Pieri L; Domenici L; Romagnoli P
    Ital J Anat Embryol; 2006; 111(3):133-49. PubMed ID: 17312920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal Langerhans' cells and their function in the skin immune system.
    Hogan AD; Burks AW
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):5-10; quiz 10-2. PubMed ID: 7621061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the number and morphology of Langerhans' cells in the epidermal component of squamous cell carcinomas.
    Alcalay J; Goldberg LH; Wolf JE; Kripke ML
    Arch Dermatol; 1989 Jul; 125(7):917-20. PubMed ID: 2742388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
    Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
    Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of grenz rays on Langerhans' cells in human epidermis.
    Lindelöf B; Lidén S; Ros AM
    Acta Derm Venereol; 1984; 64(5):436-8. PubMed ID: 6208727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive changes in the Langerhans' cells of human skin caused by occlusion with water and sodium lauryl sulphate.
    Mikulowska A
    Acta Derm Venereol; 1990; 70(6):468-73. PubMed ID: 1981417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
    Czernielewski J; Juhlin L; Shroot S; Brun P
    Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.